Hvivo Plc Is A Uk Based Contract Research Organizationcrothat Specializes In Human Challenge Trials And Early Phase Clinical Developmentheadquartered In Londonthe Company Has Been Operational Since February 2011 And Is Publicly Traded On The London Stock Exchange Under The Ticker Hvothe Company Is Recognized As A Leader In Human Challenge Trialsoffering Services Such As Human Challenge Models For Infectious And Respiratory Diseaseschallenge Agent Manufacturingand Laboratory Servicesthrough Its Subsidiariesincluding Venn Life Sciences And Crshvivo Provides Comprehensive Drug Development Solutionsfrom Preclinical Studies To Phase Ii Trialstheir Expertise Includes Vaccine Efficacy Testing And Specialized Research In Respiratory Diseasesdrawing On A Rich Legacy From The Uk Common Cold Unit Hvivo Is Committed To Ethical Clinical Practices And Environmental Sustainabilityimplementing Energy Efficiency Programs And Waste Reduction Initiativesthe Company Collaborates With Pharmaceutical Companiesgovernment Agenciesand Biotech Firms To Advance Research In Infectious Diseases
United States
